| scholarly article | Q13442814 |
| P50 | author | Jeanette Hanson | Q57012391 |
| P2093 | author name string | U Olsson | |
| B S Holst | |||
| T Fall | |||
| I Lilliehöök | |||
| M S Lewitt | |||
| E M Strage | |||
| F Norrvik | |||
| P2860 | cites work | A single IGF1 allele is a major determinant of small size in dogs | Q24645092 |
| Correct homeostasis model assessment (HOMA) evaluation uses the computer program | Q28290512 | ||
| Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms | Q29615455 | ||
| Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes | Q33523666 | ||
| Growth hormone mRNA in mammary gland tumors of dogs and cats | Q34215127 | ||
| Secretion of prolactin and growth hormone in relation to ovarian activity in the dog. | Q34368448 | ||
| C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. | Q34620307 | ||
| Connecting serum IGF-1, body size, and age in the domestic dog | Q35201151 | ||
| Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. | Q36023488 | ||
| Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes | Q36029231 | ||
| Obesity and cancer risk: the role of the insulin-IGF axis | Q36587115 | ||
| Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia | Q36741984 | ||
| Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. | Q37801276 | ||
| Prognostic studies of canine and feline mammary tumours: the need for standardized procedures | Q37980558 | ||
| Species variation in the amino acid sequence of insulin | Q38707401 | ||
| Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation | Q40835107 | ||
| Human growth hormone and human aging | Q40906146 | ||
| Anterior pituitary function in female dogs with spontaneous mammary tumors: I. Growth hormone | Q41260556 | ||
| Progestin treatment in the dog. I. Effects on growth hormone, insulin-like growth factor I and glucose homeostasis | Q42491637 | ||
| Diabetes mellitus in elkhounds is associated with diestrus and pregnancy | Q42835306 | ||
| Basal measures of insulin sensitivity and insulin secretion and simplified glucose tolerance tests in dogs | Q42945105 | ||
| Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer. | Q43104484 | ||
| Accuracy of canine parturition date prediction from the initial rise in preovulatory progesterone concentration | Q44560425 | ||
| Insulin resistance and changes in plasma concentration of TNFalpha, IGF1, and NEFA in dogs during weight gain and obesity | Q44826390 | ||
| Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation | Q46117297 | ||
| Glucagon stimulation test for estimating endogenous insulin secretion in dogs | Q46403406 | ||
| Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours. | Q46681697 | ||
| Adenohypophyseal function in bitches treated with medroxyprogesterone acetate | Q46925179 | ||
| Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs. | Q50895668 | ||
| Evaluation of circulating concentrations of glucose homeostasis biomarkers, progesterone, and growth hormone in healthy Elkhounds during anestrus and diestrus. | Q51365046 | ||
| Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly | Q51645787 | ||
| Metasomatotrophic diabetes and its induction: basal insulin secretion and insulin release responses to glucose, glucagon, arginine and meals. | Q51659703 | ||
| Diabetes mellitus in a population of 180,000 insured dogs: incidence, survival, and breed distribution. | Q51719425 | ||
| Somatogenic receptors of rat liver: regulation by insulin. | Q54547811 | ||
| Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy | Q67022520 | ||
| Insulin-like growth factor I in the dog: a study in different dog breeds and in dogs with growth hormone elevation | Q70329530 | ||
| Influence of medroxyprogesterone acetate (Provera) on plasma growth hormone levels and on carbohydrate metabolism. I. Studies in the ovariohysterectomized bitch | Q70559426 | ||
| Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases | Q70583010 | ||
| Progestin-induced growth hormone excess in the dog originates in the mammary gland | Q71605073 | ||
| Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999) | Q77146169 | ||
| Hormonal disturbances associated with obesity in dogs | Q80226929 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| P304 | page(s) | 419-428 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Journal of Veterinary Internal Medicine | Q15762439 |
| P1476 | title | Relationship among insulin resistance, growth hormone, and insulin-like growth factor I concentrations in diestrous Swedish Elkhounds | |
| P478 | volume | 28 |
Search more.